Delivery Order SPE2DB22D1052-SPE2DB25FU7WS
Award Date
10/29/24
Potential Completion Date
10/30/24
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FC0L5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 25 mg capsules, a prescription medication, with a ceiling value of $3,139.12. The contract is a Firm Fixed Price Delivery Order with a performance period extending to May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 50 mg capsules. The contract has a ceiling value of $2,693.70 and a period of performance that runs through July 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle with the DLA, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary mechanism for...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the supply of Lyrica 75 mg capsules. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,295.98 and a performance period ending on June 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $3,638.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Lyrica 25 mg capsules, a prescription medication, with a period of performance through May 1, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF0FZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a pharmaceutical product, with a ceiling value of $3,587.94 and a completion date of December 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lyrica 75 mg capsules. The contract has a ceiling value of $5,848.25 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 5, 2024 and was awarded on March 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds an...
This federal contract award, SPE2DB22D1106|SPE2DB25FELA2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm-fixed price for the supply of Lyrica 225 mg capsules. The award has a ceiling value of $1,203.12 and an ultimate completion date of April 30, 2025. The contract is not set-aside and is open to competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,778.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 100 mg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 150 mg capsules. The $5,241.11 firm-fixed-price contract has an ultimate completion date of August 28, 2024 and was awarded on August 27, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FU14T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,708.69 firm fixed-price delivery order contract is for the provision of Lyrica 75 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...